Most Popular Articles

Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study

Donina, Simona; Strele, Ieva; Proboka, Guna; More

Melanoma Research. 25(5):421-426, October 2015.

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma

Hintzsche, Jennifer D.; Gorden, Nicholas T.; Amato, Carol M.; More

Melanoma Research. 27(3):189-199, June 2017.

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; More

Melanoma Research. 27(4):358-368, August 2017.

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study

Guadagni, Stefano; Fiorentini, Giammaria; Clementi, Marco; More

Melanoma Research. 27(5):439-447, October 2017.

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Espinosa, Enrique; Soriano, Virtudes; Malvehy, Josep; More

Melanoma Research. 26(3):278-283, June 2016.

LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis

De Araújo, Érica S.S.; Kashiwabara, André Y.; Achatz, Maria I.W.; More

Melanoma Research. 25(2):173-177, April 2015.

Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program

Berrocal, Alfonso; Arance, Ana; Lopez Martin, Jose Antonio; More

Melanoma Research. 24(6):577-583, December 2014.

  • Open Access Icon